Niioka T

References (2)

Title : Abnormally high plasma concentrations of M-4, the active metabolite of edoxaban, at the onset of acute kidney injury in a patient receiving rifampin and clarithromycin: a case report - Nakagawa_2024_J.Pharm.Health.Care.Sci_10_66
Author(s) : Nakagawa J , Ishido K , Kimura N , Nagase H , Wakasa Y , Yokoyama S , Ueno K , Hakamada K , Niioka T
Ref : J Pharm Health Care Sci , 10 :66 , 2024
Abstract :
PubMedSearch : Nakagawa_2024_J.Pharm.Health.Care.Sci_10_66
PubMedID: 39468637

Title : Associations among plasma concentrations of edoxaban and M-4, prothrombin time, and the SLCO1B1*15 haplotype in patients with non-valvular atrial fibrillation - Nakagawa_2022_Ther.Drug.Monit__
Author(s) : Nakagawa J , Kinjo T , Aiuchi N , Ueno K , Tomita H , Niioka T
Ref : Ther Drug Monit , : , 2022
Abstract :
PubMedSearch : Nakagawa_2022_Ther.Drug.Monit__
PubMedID: 36150716